We have started switching small amounts of our 25% Stablecoin exposure back into blue chip cryptos following recent declines. There is likely to be more opportunities with momentum pointing lower.
There are many innovations that are changing the potential way we invest. @enzymefinance has delivered a solid asset management protocol that we started testing at the end of December. Decent return so far in the Growth portfolio.
#DeFi#blockchain#investing